• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清胰岛素样生长因子-I(IGF-I)水平低与血管性痴呆的风险增加有关。

Low serum insulin-like growth factor-I (IGF-I) level is associated with increased risk of vascular dementia.

机构信息

Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, SE-413 45 Gothenburg, Sweden.

Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, SE-431 80 Mölndal, Sweden.

出版信息

Psychoneuroendocrinology. 2017 Dec;86:169-175. doi: 10.1016/j.psyneuen.2017.09.018. Epub 2017 Sep 21.

DOI:10.1016/j.psyneuen.2017.09.018
PMID:28963885
Abstract

BACKGROUND

Insulin-like growth factor-I (IGF-I) is important for the adult brain, but little is known of the role of IGF-I in Alzheimeŕs disease (AD) or vascular dementia (VaD).

METHODS

A prospective study of 342 patients with subjective or objective mild cognitive impairment recruited at a single memory clinic. We determined whether serum IGF-I concentrations at baseline were associated with the risk of all-cause dementia, AD, or VaD. Patients developing mixed forms of AD and VaD were defined as suffering from VaD. The statistical analyses included Cox proportional hazards regression analysis.

RESULTS

During the follow-up (mean 3.6 years), 95 (28%) of the patients developed all-cause dementia [AD, n=37 (11%) and VaD, n=42 (12%)]. Low as well as high serum IGF-I (quartile 1 or 4 vs. quartiles 2-3) did not associate with all-cause dementia [crude hazard ratio (HR) 1.30, 95% confidence interval (CI): 0.81-2.08 and crude HR 1.05, 95% CI: 0.63-1.75, respectively] or AD (crude HR 0.79, 95% CI: 0.35-1.79 and crude HR 0.94, 95% CI: 0.43-2.06, respectively]. In contrast, low serum IGF-I concentrations were associated with increased risk of VaD (quartile 1 vs. quartiles 2-3, crude HR 2.22, 95% CI: 1.13-4.36). The latter association remained significant also after adjustment for multiple covariates.

CONCLUSIONS

In a memory clinic population, low serum IGF-I was a risk marker for subsequent VaD whereas low IGF-I did not associate with the risk of AD. High serum IGF-I was not related to the risk of conversion to dementia.

摘要

背景

胰岛素样生长因子-I(IGF-I)对成人大脑很重要,但对于 IGF-I 在阿尔茨海默病(AD)或血管性痴呆(VaD)中的作用知之甚少。

方法

这是一项在单个记忆诊所招募的 342 名主观或客观轻度认知障碍患者的前瞻性研究。我们确定基线时血清 IGF-I 浓度是否与全因痴呆、AD 或 VaD 的风险相关。发展为 AD 和 VaD 混合形式的患者被定义为患有 VaD。统计分析包括 Cox 比例风险回归分析。

结果

在随访期间(平均 3.6 年),95 名(28%)患者发生全因痴呆[AD,n=37(11%)和 VaD,n=42(12%)]。低浓度和高浓度的血清 IGF-I(第 1 或 4 四分位数与第 2-3 四分位数相比)与全因痴呆[粗危险比(HR)1.30,95%置信区间(CI):0.81-2.08 和粗 HR 1.05,95% CI:0.63-1.75]或 AD(粗 HR 0.79,95% CI:0.35-1.79 和粗 HR 0.94,95% CI:0.43-2.06)无关。相反,低浓度的血清 IGF-I 与 VaD 的风险增加相关(第 1 四分位数与第 2-3 四分位数相比,粗 HR 2.22,95% CI:1.13-4.36)。在调整了多个协变量后,这种关联仍然具有统计学意义。

结论

在记忆诊所人群中,低浓度的血清 IGF-I 是 VaD 发生的风险标志物,而低 IGF-I 与 AD 的风险无关。高浓度的血清 IGF-I 与痴呆转化的风险无关。

相似文献

1
Low serum insulin-like growth factor-I (IGF-I) level is associated with increased risk of vascular dementia.血清胰岛素样生长因子-I(IGF-I)水平低与血管性痴呆的风险增加有关。
Psychoneuroendocrinology. 2017 Dec;86:169-175. doi: 10.1016/j.psyneuen.2017.09.018. Epub 2017 Sep 21.
2
Low serum concentration of free triiodothyronine (FT3) is associated with increased risk of Alzheimer's disease.血清游离三碘甲状腺原氨酸(FT3)浓度降低与阿尔茨海默病风险增加相关。
Psychoneuroendocrinology. 2019 Jan;99:112-119. doi: 10.1016/j.psyneuen.2018.09.002. Epub 2018 Sep 5.
3
Relationship between serum insulin-like growth factor-1 levels and Alzheimer's disease and vascular dementia.血清胰岛素样生长因子-1水平与阿尔茨海默病及血管性痴呆之间的关系。
J Am Geriatr Soc. 2005 Oct;53(10):1748-53. doi: 10.1111/j.1532-5415.2005.53524.x.
4
Serum but not cerebrospinal fluid levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 (IGFBP-3) are increased in Alzheimer's disease.血清而非脑脊液中的胰岛素样生长因子-I(IGF-I)和 IGF 结合蛋白-3(IGFBP-3)水平在阿尔茨海默病中升高。
Psychoneuroendocrinology. 2013 Sep;38(9):1729-37. doi: 10.1016/j.psyneuen.2013.02.006. Epub 2013 Mar 6.
5
The role of human kallikrein 6, clusterin and adiponectin as potential blood biomarkers of dementia.人激肽释放酶6、簇集素和脂联素作为痴呆潜在血液生物标志物的作用。
Clin Biochem. 2016 Feb;49(3):213-8. doi: 10.1016/j.clinbiochem.2015.10.014. Epub 2015 Oct 26.
6
Insulin-like growth factor-I and insulin-like growth factor binding protein-3 in Alzheimer's disease.阿尔茨海默病中的胰岛素样生长因子-I 和胰岛素样生长因子结合蛋白-3。
J Clin Endocrinol Metab. 2012 Dec;97(12):4673-81. doi: 10.1210/jc.2012-2063. Epub 2012 Sep 26.
7
Serum thyroid-stimulating hormone as a predictor of cognitive impairment in an elderly cohort.血清促甲状腺激素可预测老年人群认知障碍
Gerontology. 2012;58(1):41-9. doi: 10.1159/000324522. Epub 2011 Mar 23.
8
Day-to-Day Blood Pressure Variability and Risk of Dementia in a General Japanese Elderly Population: The Hisayama Study.日本普通老年人群的日常血压变异性与痴呆风险:久山研究
Circulation. 2017 Aug 8;136(6):516-525. doi: 10.1161/CIRCULATIONAHA.116.025667.
9
Small dense low-density lipoprotein and carotid atherosclerosis in relation to vascular dementia.小而密低密度脂蛋白与颈动脉粥样硬化和血管性痴呆的关系
Metabolism. 2004 Apr;53(4):476-82. doi: 10.1016/j.metabol.2003.11.020.
10
Insulin-like growth factor-1 and risk of Alzheimer dementia and brain atrophy.胰岛素样生长因子-1 与阿尔茨海默病痴呆和脑萎缩的风险。
Neurology. 2014 May 6;82(18):1613-9. doi: 10.1212/WNL.0000000000000382. Epub 2014 Apr 4.

引用本文的文献

1
The Associations Between Serum Insulin-like Growth Factor-I, Brain White Matter Volumes, and Cognition in Mild Cognitive Impairment and Alzheimer's Disease.血清胰岛素样生长因子-I 与脑白质体积及轻度认知障碍和阿尔茨海默病认知的相关性。
J Alzheimers Dis. 2024;99(2):609-622. doi: 10.3233/JAD-231026.
2
Molecular biomarkers for vascular cognitive impairment and dementia.血管性认知障碍和痴呆的分子生物标志物。
Nat Rev Neurol. 2023 Dec;19(12):737-753. doi: 10.1038/s41582-023-00884-1. Epub 2023 Nov 13.
3
Repositioning of Anti-Diabetic Drugs against Dementia: Insight from Molecular Perspectives to Clinical Trials.
抗糖尿病药物对痴呆症的重新定位:从分子角度到临床试验的洞察。
Int J Mol Sci. 2023 Jul 14;24(14):11450. doi: 10.3390/ijms241411450.
4
Insulin resistance, cognition, and Alzheimer disease.胰岛素抵抗、认知和阿尔茨海默病。
Obesity (Silver Spring). 2023 Jun;31(6):1486-1498. doi: 10.1002/oby.23761.
5
Effects of Resistance Exercise on Neuroprotective Factors in Middle and Late Life: A Systematic Review and Meta-Analysis.抗阻运动对中老年神经保护因子的影响:一项系统综述与荟萃分析
Aging Dis. 2023 Aug 1;14(4):1264-1275. doi: 10.14336/AD.2022.1207.
6
Cell non-autonomous regulation of cerebrovascular aging processes by the somatotropic axis.体轴对脑血管衰老过程的非自主调控。
Front Endocrinol (Lausanne). 2023 Jan 23;14:1087053. doi: 10.3389/fendo.2023.1087053. eCollection 2023.
7
Identification of the molecular mechanism of insulin-like growth factor-1 (IGF-1): a promising therapeutic target for neurodegenerative diseases associated with metabolic syndrome.胰岛素样生长因子-1(IGF-1)分子机制的鉴定:代谢综合征相关神经退行性疾病的一个有前景的治疗靶点。
Cell Biosci. 2023 Jan 23;13(1):16. doi: 10.1186/s13578-023-00966-z.
8
Growth Hormone Receptor Regulation in Cancer and Chronic Diseases.生长激素受体在癌症和慢性疾病中的调控。
Front Endocrinol (Lausanne). 2020 Nov 18;11:597573. doi: 10.3389/fendo.2020.597573. eCollection 2020.
9
Blood-based biomarkers in hypothalamic-pituitary axes for the risk of dementia or cognitive decline: a systematic review and meta-analysis.基于下丘脑-垂体轴的血液生物标志物与痴呆或认知能力下降风险的相关性:系统评价和荟萃分析。
Aging (Albany NY). 2020 Oct 26;12(20):20350-20365. doi: 10.18632/aging.103813.
10
The role of exercise in the reversal of IGF-1 deficiencies in microvascular rarefaction and hypertension.运动在逆转微血管稀疏和高血压中 IGF-1 缺乏的作用。
Geroscience. 2020 Feb;42(1):141-158. doi: 10.1007/s11357-019-00139-2. Epub 2019 Dec 5.